Skip to content

13F-HR filed by SAMSARA BIOCAPITAL, LLC

SAMSARA BIOCAPITAL, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 43 holding rows worth $728,583,411.

Accession
0001104659-25-014316
Filed
2025-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 43 entries on the cover page, a total value of $728,583,411 stated on the cover page (in dollars after the unit check, H1), rows summing to $728,583,411 with VALUE read as dollars as filed, 13F file number 028-19375. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SCHOLAR ROCK HLDG CORP80706P103COM5,612,896$242,589,365dollars as filed
CARGO THERAPEUTICS INC COM14179K101Stock4,415,689$63,674,235dollars as filed
SEPTERNA INC COM81734D104Stock2,768,520$63,399,108dollars as filed
MINERALYS THERAPEUTICS INC603170101COM5,074,916$62,472,216dollars as filed
NEUROGENE INC64135M105COMMON STOCK1,717,127$39,253,523dollars as filed
UPSTREAM BIO INC91678A107COMMON STOCK2,217,146$36,449,880dollars as filed
LENZ THERAPEUTICS INC52635N103COM986,981$28,494,141dollars as filed
ALUMIS INC022307102COM3,266,498$25,674,674dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock253,641$19,451,728dollars as filed
ZYMEWORKS INC98985Y108COM1,000,000$14,640,000dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW584,642$12,499,646dollars as filed
AVADEL PHARMACEUTICALS PLCG29687103COM SHS967,527$10,168,709dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM172,647$9,664,779dollars as filed
NKARTA INC65487U108COMMON STOCK3,768,035$9,382,407dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock588,816$8,626,154dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK679,486$8,153,832dollars as filed
ACELYRIN INC00445A100COM2,523,022$7,922,289dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A824,155$7,087,733dollars as filed
CYPHERPUNK TECHNOLOGIES INC52187K200COM NEW2,442,352$7,021,762dollars as filed
ABIVAX SA-00370M103SPONSORED ADS850,000$6,222,000dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock2,385,060$5,914,949dollars as filed
GOSSAMER BIO INC COM38341P102Stock6,130,268$5,545,440dollars as filed
CLIMB BIO INC28658R106COMMON STOCK2,609,114$4,696,405dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS97,625$4,533,705dollars as filed
INOZYME PHARMA INC45790W108COM1,562,500$4,328,125dollars as filed
SUTRO BIOPHARMA INC869367102COM2,196,814$4,042,138dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM291,666$2,939,993dollars as filed
VTV THERAPEUTICS INC918385204CL A NEW206,784$2,855,418dollars as filed
TANGO THERAPEUTICS INC87583X109COM630,000$1,946,700dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock147,319$1,866,532dollars as filed
IMMATICS N.VN44445109SHS198,000$1,407,780dollars as filed
PRIME MEDICINE INC74168J101COM405,228$1,183,266dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock202,348$1,121,008dollars as filed
HILLEVAX INC43157M102COM399,637$827,249dollars as filed
CURIS INC231269309COM198,216$606,541dollars as filed
JANUX THERAPEUTICS INC47103J105COM11,263$603,021dollars as filed
BOLT BIOTHERAPEUTICS INC097702104COM1,049,153$561,402dollars as filed
LYRA THERAPEUTICS INC55234L105COM1,965,689$405,718dollars as filed
ALLAKOS INC01671P100COM172,089$208,228dollars as filed
KRONOS BIO INC50107A104COM78,131$74,224dollars as filed
ALLOVIR INC019818103COM82,336$34,581dollars as filed
NUVATION BIO INC67080N119WARR133,333$30,667dollars as filed
SURROZEN INC86889P117*W EXP 08/01/20399,999$2,140dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-25-014316this filing2025-02-14acceptance time not in the bulk data set